Notes:1 A separate question – and – answer document here. The summary of opinion for Thalidomide Pharmion here. Thalidomide referred for the treatment of multiple myeloma as an an orphan medicinal product in November 2001. See here for a summary of positive opinion. Thalidomide is also designated as an orphan medicinal product for the treatment of graft-versus – host disease. See here for a summary of positive opinion. Thalidomide is currently approved in other countries for multiple myeloma, including Australia and the USA.
fection. -atitis C Clinical Trialdoctors at Southern Health have initiated a clinical phase IIa trial to evaluate the efficacy of a new strategy for defeating hepatitis C virus infection, one of the hardest infectious diseases in the modern world to test. Continue reading